JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB25348

APC Anti-CD45.1 antibody [A20]

Be the first to review this product! Submit a review

|

(3 Publications)

Mouse Monoclonal CD45 antibody - conjugated to APC. Suitable for Flow Cyt and reacts with Mouse samples. Cited in 3 publications.

View Alternative Names

CD45, Ly-5, Ptprc, Receptor-type tyrosine-protein phosphatase C, Leukocyte common antigen, Lymphocyte antigen 5, T200, L-CA

1 Images
Flow Cytometry - APC Anti-CD45.1 antibody [A20] (AB25348)
  • Flow Cyt

Supplier Data

Flow Cytometry - APC Anti-CD45.1 antibody [A20] (AB25348)

Flow Cytometry analysis of C57Bl/6 (left panel) or SJL (right panel) splenocytes labeling CD45.1 with ab25348 at 0.5 μg (solid line) or Mouse IgG2a (Allophycocyanin) isotype control at 0.5 μg (dashed line).

  • Unconjugated

    Anti-CD45.1 antibody [A20]

  • Cy5®

    Cy5 ® Anti-CD45.1 antibody [A20]

  • 519 FITC

    FITC Anti-CD45.1 antibody [A20]

  • Biotin

    Biotin Anti-CD45.1 antibody [A20]

  • 667 PE/Cy5®

    PE/Cy5® Anti-CD45.1 antibody [A20]

  • 695 PerCP/Cy5.5®

    PerCP/Cy5.5® Anti-CD45.1 antibody [A20]

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

A20

Isotype

IgG2a

Light chain type

kappa

Conjugation

APC

Excitation/Emission

Ex: 650nm, Em: 660nm

Carrier free

No

Reacts with

Mouse

Applications

Flow Cyt

applications

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>" } } }

You may be interested in:

AB277445

Mouse CD45 ELISA kit

0

0 Reviews

View product

We recommend this product because it’s often used in the same experiment or related research.

We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification
Storage buffer
pH: 7.2 Preservative: 0.09% Sodium azide Constituents: 0.87% Sodium chloride, 0.14% Sodium dihydrogen phosphate, 0.1% Gelatin
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Do Not Freeze|Store undiluted

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD45.1 also known as Leukocyte Common Antigen (LCA) or Protein Tyrosine Phosphatase Receptor Type C (PTPRC) is a protein expressed on the surface of all nucleated hematopoietic cells. It has a molecular mass of approximately 180-220 kDa. This protein acts as a receptor-type protein tyrosine phosphatase. CD45.1 is an essential marker in the immune system particularly found on T cells B cells and other white blood cells. The expression of CD45.1 is seen across leukocytes where it plays a significant role in cell signaling and antigen receptor signaling.
Biological function summary

CD45.1 influences the immune response by modulating signals through antigen receptors. It operates as a single-pass type I membrane protein and is not known to be part of a larger complex. This protein is important in the activation and regulation of T-cells and B-cells by fine-tuning the threshold of signals required for cell activation. The presence of CD45.1 affects multiple processes in adaptive immunity impacting lymphocyte development and their further activation in immune responses.

Pathways

CD45.1 is integral in lymphocyte activation pathways. It influences the T-cell receptor (TCR) and B-cell receptor (BCR) signaling pathways by dephosphorylating specific kinases like Lck and Fyn which are important in initiating TCR and BCR signaling cascades. Moreover CD45.1 interacts with other proteins such as CD3 and CD19 being essential in the regulation of immune response and maintaining proper signaling amplitudes to ensure effective immune function.

CD45.1 is intricately linked to autoimmune diseases and leukemia. The protein's dysregulation can lead to improper immune signaling contributing to conditions such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). In leukemia the altered expression of CD45.1 and related proteins such as CD20 often correlates with disease progression and treatment response. Understanding the roles of CD45.1 can facilitate the development of targeted therapies in these contexts.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Protein tyrosine-protein phosphatase required for T-cell activation through the antigen receptor. Acts as a positive regulator of T-cell coactivation upon binding to DPP4. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits and dephosphorylates SKAP1 and FYN (By similarity). Dephosphorylates LYN, and thereby modulates LYN activity.
See full target information Ptprc

Publications (3)

Recent publications for all applications. Explore the full list and refine your search

JCI insight 8: PubMed36394951

2023

Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Edwin Patino,Divya Bhatia,Steven Z Vance,Ada Antypiuk,Rie Uni,Chantalle Campbell,Carlo G Castillo,Shahd Jaouni,Francesca Vinchi,Mary E Choi,Oleh Akchurin

Blood 87:4049-56 PubMed8639760

1996

Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: implications for gene therapy.

Applications

Unspecified application

Species

Unspecified reactive species

M Mardiney,H L Malech

Transplantation 57:249-56 PubMed7906058

1994

The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.

Applications

Unspecified application

Species

Unspecified reactive species

D A Vallera,P A Taylor,J Sprent,B R Blazar
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Version
Primary Antibodies

AB24982

Cy5 ® Anti-CD45.1 antibody [A20]

primary-antibodies

cy5-cd451-antibody-a20-ab24982

0

(0 reviews)

Alternative Version
Primary Antibodies

AB24917

FITC Anti-CD45.1 antibody [A20]

primary-antibodies

fitc-cd451-antibody-a20-ab24917

4

(1 reviews)

Alternative Version
Primary Antibodies

AB25011

Biotin Anti-CD45.1 antibody [A20]

primary-antibodies

biotin-cd451-antibody-a20-ab25011

0

(0 reviews)

Alternative Version
Primary Antibodies

AB25349

PE/Cy5® Anti-CD45.1 antibody [A20]

primary-antibodies

pe-cy5-cd451-antibody-a20-ab25349

0

(0 reviews)

Alternative Version
Primary Antibodies

AB210237

PerCP/Cy5.5® Anti-CD45.1 antibody [A20]

primary-antibodies

percp-cy55-cd451-antibody-a20-ab210237

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com